Why Pfizer and Johnson & Johnson Fell on Friday
Two prominent U.S. coronavirus stocks ended the week on a down note. Pfizer (NYSE: PFE) and Johnson & Johnson (NYSE: JNJ) both fell on the day by nearly 3%. This followed a prominent investment bank's rather lukewarm take on their current prospects.
Goldman Sachs analyst Chris Shibutani initiated coverage on Pfizer and Johnson & Johnson on Friday, tagging both high-profile healthcare industry stocks with neutral recommendations.
Image source: Getty Images.
Source Fool.com
